Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, featuring promising developments across several health care and industrial programs. With its structural similarity to The natural way derived human serum albumin, OsrHSA provides a safer, more trusted alternative for therapeutic use, sig